The application discloses a kind of lipid-oriented
cancer cell fluorescent probes, wherein X1 is selected from C (CH3) 2, O, S or Se;A1 is selected from H, phenyl or substituted phenyl;R1, R2 can be same or different, R1 and R2 are each independently selected from C1-C8
alkyl, C1-C8 hydroxyl, C1-C8 carboxyl, C 1‑8 NR 5 R 6 , C1-C8 ester group, benzyl and substituted benzyl;The substituted benzyl is optionally substituted by C1-C8
alkyl, C1-C8 alkoxy, CN, COOH, NH2, NO2, OH, SH,
halogen or C1-C8 haloalkyl;Y ‑ Is selected from
halogen negative
ion, CIO4 ‑ , PF6 ‑ , CH3COO ‑ Or OTs ‑ . The fluorescent probe utilizes carbon-carbon
double bond to connect
benzothiazole and
quinoline part to form Donor-Accepter structure, has the
advantage of
nucleic acid response, and the probe molecule can be based on the content of
cell membrane lipid Different normal cells / tissues and
cancer cells / tissues are distinguished, selectively enter
cancer cells and combine with
nucleic acid to produce
fluorescence. The fluorescent probe can be used for tumor
cell or
tissue specific fluorescence imaging based on
nucleic acid detection.